DxGen is Point-Of-Care (POC) diagnostics company devoted to developing multi-markers for people's healthcare as Diabetes and Tuberculosis. The systems are designed specifically to care for entire stage of Diabetes. Epithod®616 (semi-automated) and Epithod®AutoDx (automated) are the POCT analyzers for measuring HbA1c, Glycated Albumin and Tuberculosis Ag. Furthermore the next parameters are planning to expand as CRP/hs-CRP, Hemoglobin, Micro-Albumin and so on.